ÂÜÀòÂÒÂ×

Sara Sinicropi-Yao is a Principal Scientist in Translational Biology at Auron Therapeutics, with prior experience as an Investigator in Tumor Biology at H3 Biomedicine and as a Postdoctoral Fellow at Sanofi. Sara held postdoctoral research positions at The Ohio State University College of Medicine and has a background in Biomedical Sciences Graduate Research. Prior roles include Research Associate positions at Eli Lilly and Company, Biogen Idec, and a Small Startup, as well as a Summer Worker at Abbott Bioresearch Center. Sara holds a Bachelor of Science in Sociology with a Minor in Chemistry from Bates College and a Doctor of Philosophy in Biomedical Sciences from The Ohio State University College of Medicine.